Title: Astrocyte Elevated Gene-1 in Breast Cancer: An Oncogenic Role and Prognostic Implication
Dr. Mengfeng Li, Professor, Zhongshan School of Medicine, Sun Yat-sen University, China

Title: Molecular Breast Imaging, What will the Future Bring?
Dr. Khalkhali Iraj, Professor of Radiological Sciences, David Geffen School of Medicine at UCLA; Director, Breast Diagnostic Center and Outpatient Radiology Services, Harbor-UCLA Medical Center, USA

Title: Anti-mitotic Protein Atip3 is a Novel Biomarker of Invasive Breast Carcinoma of Poor Prognosis
Dr. Clara Nahmias, Research Director, Department of Cell Biology, Institute Cochin, University Paris Descartes, France

Title: Deciphering the Role of miRNAs in Hypoxia by Digital Gene Expression Profiling
Dr. Jiannis (Ioannis) Ragoussis, Head of Genomics Research, Wellcome Trust Centre for Human Genetics, University of Oxford, UK

Title: Fox Proteins in Basal-like Breast Cancer
Dr. Xiaojiang Cui, Assistant Professor, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, USA

Title: What is the Link between Autophagy and Antiestrogen Resistance in Breast Cancer?
Dr. Patricia Schoenlein, Associate Professor, Department of Cellular Biology and Anatomy, Member of the MCG Cancer Center, Medical College of Georgia, USA

Title: Annexin-1 as a Biomarker and Critical Regulator of Breast Cancer Growth and Metastasis
Dr. Lina HK Lim, Assistant Professor, Department of Physiology & NUS Immunology Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Title: Discovering Interactions among BRCA1 and other Genes Associated with Breast Cancer
Dr. Shaw-Hwa Lo, Professor, Department of Statistics, Columbia University, USA

Title: Expression Profile and Function Analysis of miRNAs in Breast Cancer Stem Cells
Dr. Zheng-tang Chen, Professor and Director of The Cancer Institute of PLA, Xin-qiao Hospital, Third Military Medical University, China

13:30-13:55

Title: Reliability of Chromogenic in Situ Hybridization (CISH) for Detecting Her2 Gene Status in Breast Carcinoma: A Multicenter Study Using Conventional Scoring Criteria and the New ASCO/CAP Recommendations
Dr. Yun Gong, Associate Professor, Department of Pathology, University of Texas M.D. Anderson Cancer Center, USA     

13:55-14:20

Title: Does Exposure to Persistent Organic Pollutants (POPS) Increase the Risk of Breast Cancer?
Dr. Eva Cecilie Bonefeld-Jorgensen, Director, Associated Professor, Centre of Arctic Environmental Medicine, Unit of Cellular and Molecular Toxicology, School of Public Health, University of Aarhus, Denmark

14:20-14:45

Title: Cell Cycle Checkpoints and Breast Cancer
Dr. Xingzhi (Xavier) Xu, Professor, College of Life Science, Capital Normal University, China

14:45-15:10

Title: Does the Anthracycline Tolerance Differs in the Mediterrenean Societies?
Dr. Serdar Turhal, Professor, Division of Oncology, Marmara University, Turkey

15:10-15:25

Coffee Break

15:25-15:50

Title:  HER2 Testing in Breast Cancer - The 2007 ASCO/CAP Guidelines on HER2 Interpretation and an Update
Dr. Beiyun Chen, Associate Professor of Laboratory Medicine and Patholog, Mayo Clinic, USA

15:50-16:15

Title: Tyrosine 1248-phosphorylated HER2 Expression and HER2 Gene Amplification in Invasive Ductal Carcinomas
Dr. Kiyomi Taniyama, Director, Institute for Clinical Research, National Hospital Organization and Kure Medical Center and Chugoku Cancer Center, Japan

16:15-16:40

Title: Exposure to Perfluorinated Compounds and the Risk of Breast Cancer in Greenlandic Inuit
Dr. Manhai Long, Assistant Professor, Centre of Arctic Environmental Medicine, Unit of Cellular & Molecular Toxicology, School of Public Health, University of Aarhus, Denmark

16:40-17:05

Title: Overexpression of Fatty Acid Binding Protein-7 Correlated with Basal-like Subtype of Breast Cancer
Dr. Xiaoyan Tang, Associate Professor, Department of Pathology, Tokai University School of Medicine, Japan

Title: Relationship between Apical Polarity, Early Stages in Mammary Cancer Development and Alterations in the Transcription of Genes Linked to Cellular Homeostasis and Breast Cancer
Dr. Sophie Lelievre, Associate Professor of Basic Medical Sciences, Leader, Breast Cancer Discovery Group, Purdue Cancer Center, Purdue University, USA

Title: A Molecular Mechanism for Mammary Epithelial Differentiation Linked to BRCA1 and Risk of Breast Cancer
Dr. Chris Maxwell, Assistant Professor, Child and Family Research Institute, University of British Columbia, Canada

Title: Hypermethylation of Tumor Suppressor Genes is Correlated to Hormone Receptor Status in Breast Cancers
Dr. Yinhua Yu, Professor, Director of Molecular Pathology Laboratory, Shanghai Ob/Gyn Hospital of Fudan University, China

Title: Searching Non- BRCA Genes in Hereditary Susceptibility Breast Cancer of Javanese Young Onsets
Dr. Samuel J.Haryono,Surgical Oncolologist from Dharmais Cancer Center Jakarta, Indonesia

Dr. Shou-Jen Kuo, Superintendent, Changhua Christian Hospital, Taiwan

Dr. Myrto Petreas, Chief, Environmental Chemistry Branch, California Department of Toxic Substances Control, USA  

08:30-08:55

Title: Triple Negative Breast Carcinoma is a Prognostic Factor in Taiwanese Women
Dr. Shou-Jen Kuo, Superintendent, Changhua Christian Hospital, Taiwan

08:55-09:20

Title: Midwestern U.S. Safety Net Hospital Breast Cancer Epidemiology and Disparity of Care of African American and Hispanic Women
Dr. Glenn E. Talboy, Jr., Interim Chairman of Surgery, Associate Professor of Surgery, Program Director, University of Missouri Kansas City, USA

09:20-09:45

Title: Breast Cancer Susceptibility Loci Identification by Meta-analysis
Dr. Li Su, Professor, College of Life Science and Technology, Huazhong University of Science and Technology, China

09:45-10:10

Title: Persistent Organic Contaminants and Breast Cancer
Dr. Myrto Petreas, Chief, Environmental Chemistry Branch, California Department of Toxic Substances Control, USA  

10:10-10:25

Coffee Break

10:25-10:50

Title: Prevention Efforts in Individuals Counseling for BRCA1 and BRCA2 Mutations 
Dr. Kimberly M. Kelly, Assistant Professor, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, USA

10:50-11: 15

Title: Survival Analysis of Women Diagnosed with Breast Cancer in Iran
Dr. Abbas Rezaianzadeh, Assistant Professor, Department of Epidemiology, Shiraz University of Medical Sciences, Iran

Dr. Dorothy Pathak, Professor of Epidemiology and Family Practice, Michigan State University, USA

Dr. Edibaldo Silva, Associate Professor, Division of Surgical Oncology; Program Leader, Melanoma & Soft Tissue Sarcoma Section, University of Nebraska Medical Center, Eppley Cancer Center, USA

08:30-08:55

Title: Contribution of Migrant Studies to Understanding Breast Cancer Etiology
Dr. Dorothy R. Pathak, Professor of Epidemiology and Family Practice, Michigan State University, USA

08:55-09:20

Title: Characteristics and Developmental Trend of Breast Cancer from Western Region of Inner Mongolia
Dr. Xiulan Su, Professor,Clinical Medical Research Center, Inner Mongolia Medical College Affiliated Hospital, China

09:20-09:45

Title: Management of the Potential BRCA Carrier with Cancer
Dr. Edibaldo Silva, Associate Professor, Division of Surgical Oncology; Program Leader, Melanoma & Soft Tissue Sarcoma Section, University of Nebraska Medical Center, Eppley Cancer Center, USA

09:45-10:10

Title: Epidemiology of Breast Cancer in Southern Iran
Dr. Seyed Vahid Hosseini, Professor, Department of General Surgery, Faghihi Hospital, Shiraz University of Medical Sciences, Iran

Coffee Break

10:25-10:50

Title: Clinicopathological Profile and Survival of Breast Cancer in Asia Differs from Western Countries?
Dr. Teguh Aryandono,Professor and Head, Department of Surgery, Faculty of Medicine, Gadjah Mada University, Indonesia

10:50-11:15

Title: Curcumin in Prevention and Treatment of Breast Cancer
Dr. Navneet Kaur, Professor,Department of Surgery, University College of Medical Sciences & GTB hospital, India

Title: Breast Cancer Risk and Thrombophilic Polymorphisms
Dr. Aydan Eroglu, Associate Professor, Department of General Surgery-Surgical Oncology, Ankara University Medical School, Turkey

11:15-12:05

Panel Discussion: Topics will be proposed by Session Chairs

Dr. Bernard Friedenson, Professor, Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago University, USA

Title: Inflammation Increases Risks for Cancers in Specific Organs in Carriers of Brca1/2 Pathway Mutations
Dr. Bernard Friedenson, Professor, Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago Uic, USA

Title: Moving Forward with an Immunotherapy for the Prevention of Breast Cancer Recurrence
Dr. Thomas Kieber-Emmons, Professor, Department of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, USA

Title: Molecular Signature and Epigenetic Changes in the Chemoprevention of Mammary Carcinoma by Probiotics: Role of IL-6
Dr. Chantal Matar, Professor in the Nutrition Program, Faculty of Health Sciences, University of Ottawa, Canada

Title: Cryoimmunotherapy for Refractory Metastatic Breast Cancer with Bone Metastases
Dr. Michael Har-Noy, CEO/CTO, Immunovative Therapies, Ltd., Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Israel 

10:25-10:45

Title: The Combination Therapy of Trastuzumab and Adoptive Cell Therapy for Refractory Breast Cancer
Dr. Uhi Toh, Assistant Professor and Chief, Division of Breast Surgery, Department of Surgery, Kurume University School of Medicine, Japan

10:45-11:10

Title: The Dog as a Model for the Study of Human Inflammatory Breast Cancer
Dr. Laura Peña, Associate Professor, Department of Animal Pathology II. Veterinary School, Complutense University Madrid, University of Madrid, Spain

11:10-11:35

Title: Redirection of Tumor Associated Inflammation from Tumor-enhancing to Tumor-destructive Mode: Relevance to the Treatment of Inflammatory Breast Cancer
Dr. Jacob Shoham, Professor of Life Sciences, The Mina and Everard Goodman; Faculty of Life Sciences, Bar-Ilan University, Israel

11:35-12:00

Title: Contribution of Tumor Microenvironment in Inflammatory Breast Cancer Progression
Dr. Mona Mostafa Mohamed, Associate Professor, Head of Cancer Biology Research Laboratory, Faculty of Science, Cairo University, Egypt

13:30-13:50

Title: Molecular and Pharmacological Characterization of Cancer Stem Cell Derived from Feline Mammary Carcinomas
Dr. Angelo Ferrari, Director, National Reference Center for Veterinarian and Comparative Oncology (CEROVEC), Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, Italy

13:50-14:10

Title: Fluidigm BioMark Real-time System-Novel Single-Cell Multi-Gene Expression Analysis System
Dr. Hazelle Lam, Director, Regional (Asia) Market, Fluidigm Corporation, USA

Dr. Anthony M. Magliocco, Associate Professor and Division Head, Department of Oncology, Pathology and Laboratory Medicine, University of Calgary; Director, Translational Laboratory, Tom Baker Cancer Centre; Chairman, Pathology Committee, Radiation Therapy Oncology Group (RTOG); Medical and Scientific Director, Alberta Research Tumor Bank, Canada

Title: Effect of Extracellular Matrix (ECM) Proteins in Bone Metastasis of Breast Cancer
Dr. Jinkun (Jake) Chen, Professor, School of Dental Medicine, School of Medicine, Tufts University, USA

Title: The Role of Patient Advocacy in the Laboratory Research Setting-- Making an Impact on Metastatic Breast Cancer through the Rapid Autopsy Program
Dr. Lillie Shockney, Administrative Director; Distinguished Service Assistant Professor of Breast Cancer; Assistant Professor, Departments of Surgery and Gynecology, JHU School of Medicine; Assistant Professor, JH School of Nursing; Johns Hopkins Avon Foundation Breast Center, USA

Coffee Break

Title: Metastasis Genes as Breast Cancer Progression Markers
Dr. Georg F. Weber, Associate Professor, College of Pharmacy, University of Cincinnati, USA

Title: Blood-brain Barrier is the Bottle Neck of Targeted Therapies for Brain Metastatic Breast Cancer
Dr. Jian Yi  (Jim) Li, Chief of Division of Neuropathology, Department of Pathology and Lab Medicine, North Shore University Hospital-Long Island Jewish Medical Center, Harvey Cushing Brain Tumor Institute, The Feinstein Institute for Medical Research, North Shore-LIJ Health System, USA

Title: Tumor Homeostasis, Tumor Dormancy and Surgery-driven Enhancement of Metastasis Development Provide a New Biological Paradigm for Breast Cancer
Dr. Romano Demicheli, Professor, Department of Medical Oncology, National Cancer Institute of Milan, Italy

Title: Corning Osteo Assay Surface for Bone Resorption in Cancer Metastasis
Dr. Hongwei (Hanna) Rao, Senior Research Scientist, SP-FR-01-R1N21T, Biochemical Technologies, Corning Inc., USA

13:30-13:50

Title: EMT, Breast Cancer Invasion and Metastasis
Dr. Jihe Zhao, Associate Professor, Center for Cell Biology and Cancer Research, Albany Medical College, USA

13:50 -14:10

Title: Cancer-associated Fibroblasts and Microvascular Proliferation in Neuroblastoma Tumors
Dr. Rana Zeine, Associate Director and Research Assistant Professor (former), Northwestern University R.H. Lurie Comprehensive Cancer Center, USA

14:10-14:30

Title: Capturing and Characterizing Immune Cells from Breast Tumor Microenvironment: An Innovative Surgical Approach
Dr. Mohamed El-Sayed El-Shinawi, Assistant Professor of General Surgery, Ain Shams University-Cairo, Egypt

Title: Cell Shape is a Key Determinant of Estrogen Biosynthesis in Adipose Stromal Cells (ASCs)
Dr. Rong Li, Professor, Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, USA

Title: Mechanisms of ERβ Regulation in Breast Cancer
Dr. Valerie Speirs, Reader in Cellular Pathology, Breast Research Group, Leeds Institute of Molecular Medicine, St James's University Hospital, UK

Title: The Relevance of Phosphorylated Estrogen Receptor Alpha Profiling in Human Breast Cancer in Vivo
Dr. Georgios Skliris, Senior Scientist, Molecular Pathology, Infinity Pharmaceuticals, USA

Title: RNA Aptamer Targeting of Osteopontin in Breast Cancer Growth and Mestastasis
Dr. Paul C. Kuo, Professor of Surgery, Chief, Division of General Surgery, Vice Chair for Research, Duke University Medical Center, USA

Title: Inhibition of Epithelial-mesenchymal Transition and Breast Cancer Metastasis by TGF-beta Antagonists
Dr. LuZhe Sun, Professor, Department of Cellular & Structural Biology, Dielmann Endowed Chair in Oncology; Associate Director for Translational Research, Cancer Treatment and Research Center, University of Texas Health Science Center at San Antonio, USA

Title: Methodological Approaches in Application of Synthetic Lethality Screening towards Anticancer Therapy
Dr. Dan Canaani, Professor and Chairman, Faculty of Life Sciences, Tel-Aviv University, Israel

Title: Repression of Mn-superoxide Dismutase Expression by PPARγ Activation is a Potential New Approach for Specific Inhibition of Breast Cancer Cells’ Growth in Vitro and in Vivo
Dr. Alan Prem Kumar, Senior Scientist/Adjunct Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Session Chair:

Dr. Helena Jernstrom, Principal Investigator, Associate Professor, Department of Oncology, Clinical Sciences, Lund University, Sweden

08:30-08:55

Title: Joint Effects of Genetic Factors and Lifestyle on Hormone Levels Related to Breast Cancer Risk and Prognosis
Dr. Helena Jernstrom, Principal Investigator, Associate Professor, Department of Oncology, Clinical Sciences, Lund University, Sweden

08:55-09:20

Title: Role of Progesterone in the Etiology of Breast Cancer in an Animal Model
Dr. Sandra Z. Haslam, Professor, Department of Physiology, College of Human Medicine, Michigan State University, USA

09:20-09:45

Title: Sex Steroids and Biological Characteristics of Breast Cancers in Postmenopausal Women
Dr. Giorgio Secreto, Associate Professor, Head of Hormone Research Laboratory, National Cancer Institute, Italy

09:45-10:10

Title: Response to Trastuzumab is Mitigate by PDGF Receptors in Her2-positive Breast Cancer Cells
Dr. Tao Liu, Senior Scientist , Karolinska Institute, Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska University Hospital, Sweden

10:10-10:25

Coffee Break

Title: Using Mouse Embryonic Stem Cells and Humanized Mouse Models for Functional Analysis of Human BRCA1 and BRCA2 Variants
Dr. Shyam K. Sharan, Senior Investigator, Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Heath, USA

Title: Metastatic Tumor Model to Study Transdiaphramatic Movement of Cancer Cells Drained into Parathymic and Mammary Lymph Nodes
Dr. Gaspar Banfalvi, Professor, Department of Microbial Biotechnology and Cell Biology, University of Debrecen, Hungary

Title: Rodent Tumour Models: How Good Are They?
Dr. Ralf Brandt, CEO & Managing Director, vivoPharm Pty Ltd, Australia

Title: Oncogene-induced Senescence in Breast Cancer Suppression and Progression
Dr. Matthew Grimshaw, Senior Scientist, Vascular Biology, Centenary Institute, University of Sydney, Australia

Title: Role of the HMGA Proteins in Breast Cancer
Dr. Gennaro Chiappetta,Director and Professor, Functional Genomic Unit, Experimental Oncology Department, National Cancer Institute G. Pascale, Italy

Title: P16^ink4a Mediated Suppression of Telomerase in Normal and Malignant Human Breast
Dr. Alexey Baarov, Assistant Research Biochemist, Department of Laboratory Medicine, University of California, USA

Title: Effective Mammalian Two Hybrid Screening Reveals Novel Protein-protein Interactions in the PI3K Pathway
Dr. Zhiyong Ding, Instructor, Department of Systems Biology, The University of Texas M. D. Anderson Cancer Center, USA

Title: Pin1-Akt Oncogenic Signaling Network in Cancer
Dr. Yong Liao, Assistant Professor, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, USA

Title: Deregulation of the Tumor Suppressor Gene Lats1 in Breast Cancer Tissue
Dr. Rania Siam, Associate Professor, Department of Biology, School of Sciences and Engineering, American University in Cairo, Egypt

13:30-13:55

Title: Development of a Blood Test for Detection & Classification of Breast Disease
Dr. Richard I. Somiari, President and CSO, ITSI-Biosciences, USA

13:55-14:20

Title: How do Cancer Cells Reach the Drug Resistant Plateau? A Genomic and Proteomic Approach to the Establishment and Killing of Drug Resistant Breast Cancer Cells
Dr. Troy Harkness, Associate Professor, Department of Anatomy and Cell Biology, University of Saskatchewan, Canada

14:20-14:45

Title: Proteomic and Transcriptomic Approaches to Clinical Biomarker Discovery in Breast  Cancer
Dr. Henrik J. Ditzel, Professor, Consultant and Head, Cancer Immunology and Biomedicine, University of Southern Denmark, Denmark

14:45-15:10

Title: Gene Expression Signature of Estrogen Receptor Status for Han Chinese: The Impact of Gene Selection and Class Prediction Method
Dr. Chi-Cheng Huang, Chief, Department of Medical Research and Education, Division of General Surgery, Cathay General Hospital SiJhih, Taiwan

15:10-15:25

Coffee Break

15:25-15:50

Title: Theranostic Target: Solutions for Novel Diagnostic and Therapy Development in Breast Cancer
Dr. Ginette Serrero, CEO, A&G Pharmaceutical, USA

15:50-16:15

Title: Platelet Derived Growth Factor-C is a Therapy Target and a Novel Independent Prognostic Marker of Breast Cancer
Dr. Hong Li, Research Associate, Ludwig institute for Cancer Research, Stockholm Branch, Sweden

16:15-16:40

Title: The Molecular in Silico Dissection of Breast Cancer and its Application in Personalized Medicine
Dr.  T.A. Ayoubi, Research Manager, MicroArray Facility of the VIB, Belgium

16:40-17:05

Title : 70-gene Prognostic Signature in Breast Cancer: Pilot Study for Korean
Dr. Ku Sang Kim, Assistant Professor, Department of Surgery, Department of Medical Informatics, Ajou University School of Medicine, Ajou University Hospital Breast Cancer Center, Korea

15:10-15:30

Title: Network and Pathway Based Biomarker Analysis
Dr. Prahlad T. Ram, Associate Professor, Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, USA

15:45-16:05

Title: Multiple DNA Repair Pathways in Human Breast Cancer Risk and Progression
Dr. Jennifer J. Hu, Professor, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, USA

16:05-16:25

Title: Pathway Analysis in ER Negative Breast Cancer
Dr. Mary E. Edgerton, Associate Professor, Department of Pathology, The University of Texas School MD Anderson Cancer Center, USA

16:25-16:45

Title: Functional Proteomics by Reverse Phase Protein Array Facilitates the Identification of Biomarkers in Breast Cancer
Dr. Yiling Lu, Associate Professor, Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, USA

Title: Cell Lines as Candidate Reference Materials for Quality Control of HER2 Amplification and Expression Assays in Breast Cancer
Dr. Yan Xiao, Principle Investigator, Biochemical Science Division, National Institute of Standards and Technology, USA

Title: Breast Biomarkers : Quality Assurance and Quality Control Issues
Dr. Louis Gaboury, Associate Professor, Department of Pathology and Cell Biology; Principal Investigator, Histology Core Facility, Institute for Research in Immunology and Cancer, Canada

Title: Cytokeratin 19 Gene Expression as a Biomarker for Breast Cancer
Dr. Primchanien Moongkarndi, Associate Professor, Department of Microbiology, Faculty of Pharmacy, Mahidol University, Thailand

Dr. Christian Gespach, Research Director, Paris VI University, Hospital Saint-Antoine, France

16:45-17:05

Title: Targeting G-protein Coupled Receptor Signaling to Control Breast Cancer Progression
Dr. Christian Gespach, Research Director, Paris VI University, Hospital Saint-Antoine, France

17:05-17:25

Title: New Symmetrically Esterified M-bromobenzyl Non-aminobisphosphonates Inhibited Breast Cancer Growth and Metastases
Dr. Melanie Di Benedetto, Associate Professor, Paris 13 University, Hospital Saint Louis, CNRS FRE CSPBAT/INSERM U940, France

17:25-17:45

Title: Synthesis and Biological Evaluation of Novel Antimitotic and Antivascular Combretastatin A-4 Analogues
Dr. Mouad Alami, CNRS Research Director, Faculty of Pharmacy, University Paris-Sud, France

Title: Differential Regulation of miRNAs in Mouse Mammary Tumors induced by the Oncogene ATF3
Dr. JianJun Shen, Associate Professor, Department of Carcinogenesis, Director, Molecular Biology Resource Center, Center for Research on Environmental Disease,  The University of Texas M.D. Anderson Cancer Center, USA

Title: Biologic Profiling of Lymph Node Negative Breast Cancers by Means of microRNA Expression
Dr. Emiel AM. Janssen, Daily Leader Quantitative and Molecular Pathology, Laboratory for Molecular Biology, Department for Pathology, Stavanger University Hospital, Norway

Title: Inhibition of microRNAs on MDA-MB-231 Breast Cancer Cell Proliferation and Tumorigenic Effect
Dr. Chengfeng Yang, Assistant Professor, Department of Physiology, Center for Integrative Toxicology, Michigan State University, USA

Title: Role of microRNAs in Breast Cancer Cell Growth, Metastasis and Tamoxifen Resistance
Dr. Yin-Yuan Mo, Associate Professor, Department of Medical Microbiology, Immunology and Cell Biology, Director of SIU Cancer Institute Core Facility, Southern Illinois University School of Medicine, USA

Title: The Cross Omics Scanning and Mining Information Classification System for Notch Signaling in Breast Cancer
Dr. Leo Wang-Kit Cheung, Assistant Professor, Department of Preventive Medicine & Epidemiology; Director, Bioinformatics Core, Loyola University Medical Center, USA

Title: A Novel Way to Diagnose Breast Cancer using 21st Century Technology of Pharmacogenomics, Modified Military Infrared, Halo and Cryogenics
Dr. Phillip D Bretz,  Founder/Director – Desert Breast and Osteoporosis Institute, Inc., USA

Title: Nuclear Receptor Coregulators in Resistance to Hormone Therapy in Breast Cancer
Dr. Hao Zhang, Professor and Director of Cancer Research Center; Vice Director of Cancer Hospital, Shantou University Medical College, China

Title: Targeting Protein Kinase C: A New Front in the Treatment of Antiestrogen Resistant Breast Tumors
Dr. Kaladhar B. Reddy, Associate Professor, Department of Pathology, School of Medicine, Wayne State University, USA

Title: The Role of Forkhead Transcription Factor FOXO3a in Breast Endocrine-sensitivity and Resistance
Dr. Ui-Soon Khoo, Associate Professor, Department of Pathology, The University of Hong Kong, China

Title: Combating Prostate Cancer by Targeting Androgen Receptor with Phyto-chemical Resveratrol
Dr. Dianzheng Zhang, Assistant Professor, Department of Biochemistry/Molecular Biology, Philadelphia College of Osteopathic Medicine, USA

Dr. Ker Yu, Principal Research Scientist III, Oncology Research, Wyeth Research, USA

Keynote Speech:
Title: Targeting Kinases in Cancer
Dr. Thomas M Roberts, Professor, Department of Cancer Biology, Dana Farber Cancer Institute, Harvard Medical School, USA

Title: Global Targeting mTOR in Cancer: Thinking beyond Rapamycin
Dr. Ker Yu, Principal Research Scientist III, Wyeth Research, USA

Title: Targeting Mitochondrial Glutaminase Activity Blocks Oncogenic Transformation
Dr. Jian-Bin Wang, Research Associate Professor,  Department of Molecular Medicine, Cornell University, USA

Panel Discussion

10:25-10:50

Title: Regulation of BRCA1 and BARD1 Intracellular Trafficking and Targeting to Sites of DNA Repair
Dr. Beric Henderson, Head, Gene Expression Laboratory, Westmead Millennium Institute, University of Sydney, Australia

10:50-11:15

Title: Role of Mcm10 in Maintaining Genome Stability
Dr. Anja-Katrin Bielinsky, Associate Professor, Director of Graduate Studies, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota Medical School, USA

11:15-11:40

Title: BRCA1: A Potential Drug Target for the Anticancer Platinum Drug Cisplatin
Dr. Adisorn Ratanaphan, Associate Professor, Department of Pharmaceutical Chemistry; Faculty of Pharmaceutical Sciences, Prince of Songkla University, Thailand

Title: Targeting the KLF5 Transcription Factor for Ubiquitin Proteasome Degradation in Breast Cancer
Dr. Ceshi Chen, Associate Professor, Center for Cell Biology and Cancer Research,Albany Medical College, USA

Dr. Yanping Zhang, Professor, Department of Radiation Oncology and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, USA

08:30-08:55

Title: Ribosome Biogenesis, Cell Growth and the p53 Tumor Suppression Pathway
Dr. Yanping Zhang, Professor, Department of Radiation Oncology and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, USA

08:55-09:20

Title: Targeting the mTOR Pathway in Breast Cancer
Dr. Joseph Desoto, Assistant Professor & Director, Laboratory of Translational Oncology & Experimental Therapeutics, Uniformed Services University of the Health Sciences, USA

13:30-13:55

Title: Tamoxifen Pharmacokinetics and Pharmacodynamics,and Personalized Medicine
Dr. Ernst A. Lien, Chief Consultant, Professor, Hormone Laboratory, Haukeland University Hospital, Norway

Title: Breast Cancer Prevention by Letrozole in Post Menopausal BRCA1/2 Mutations Carriers: The onco-03/LIBER Trial
Dr. Pascal Pujol, Professor, Head of the Genetic and Cancer Department, The University Hospital of Montpellier, France

Title: Estrogen Synthesis in Human Breast Cancer Tissue: Novel Findings and Impact of Aromatase Inhibitors
Dr. Jürgen Geisler, Professor in Medical Oncology and Radiotherapy, Akershus University Hospital, University of Oslo, Norway

Title: Breast Cancer Risk of Various Hormone Regimens in Menopausal Women
Dr. Woraluk Somboonporn, Associate Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Thailand

Coffee Break

Title: Use of Array Comparative Genomic Hybridization in Breast Cancer Diagnostics
Dr. I-Tien Yeh, Professor, Director of the Core Pathology lab for the Cancer Research and Therapy Center, The University of Texas Health Science Center at San Antonio, USA

Title: Cyclin A is an Independant Prognostic Factor in Node Negative Breast Cancer
Dr. Marie-Louise Fjallskog, Associated Professor, Department of Oncology, Uppsala University, Sweden

Title: RNAs and Exosomes as Biomarkers and Potential Therapeutic Targets for Breast Cancer
Dr. Lorraine O'Driscoll, Lecturer & Principal Investigator, Head, Biomarkers & Targeted Therapies, School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin, Ireland

Panel Discussion

Title: From Morphologic Prognostic Criteria to Molecular Prognosticators
Dr. Jorg Balter, Professor, Director of Clinic Oberstetrics and Gynecology; Co-Editor, Geburtshilfe und Frauenheilkunde, Germany

Title: The hOGG1 Ser326Cys Polymorphism and Breast Cancer Risk: A Meta-Analysis
Dr. Pang Da, Professor, Heilongjiang Province Breast Cancer Center; Department of Surgery, The Third Affiliated Hospital of Harbin Medical University, China

Coffe Break

Title: Intra-tumoral Heterogeneity in Breast Cancer and its Implications for Diagnosing Breast Cancer with Small Tissue Samples
Dr. Philippe Bertheau, Professor, University Paris 7, INSERM and Hospital Saint-Louis, France

Title: Long-term Outcome of Basal-like Ductal Carcinoma in Situ in Breast Cancer
Dr. Fredrik Warnberg, Assistant Professor, Department of Surgery, Consultant in Breast Surgery, Uppsala Academic Hospital, Sweden

16:40-17:05

Title: Biological Behavior of Breast Cancer in Indian Patients: Does it Follow a Different Pattern?
Dr. Diptendra K Sarkar, Associate Professor, In Charge, Breast Service Department of Surgery, Institute of Post Graduate Medical Education and Research, India

Session Chair:

Dr. Boguslaw Tomanek, Adjunct Professor, Head MR Technology, Institute for Biodiagnostics (West), National Research Council of Canada, Canada

Co-chair:

Dr. Michael Friedrich, Professor, Director of the Department of Obstetrics and Gynecology at the Hospital Helios Klinikum Krefeld, Germany

15:25-15:45

Title: A Feasibility Study of MR Molecular Breast Imaging at 0.2t
Dr. Boguslaw Tomanek, Adjunct Professor, Head MR Technology, Institute for Biodiagnostics (West), National Research Council of Canada, Canada

15:45-16:05

Title: Ductal Carcinoma in Situ of the Breast: Diagnosis and Management
Dr. Michael Friedrich, Professor, Director of the Department of Obstetrics and Gynecology at the Hospital Helios Klinikum Krefeld, Germany

16:05-16:25

Title: Predictive Value of CD24 and CD44 for Neoadjuvant Chemotherapy Response and Prognosis in Primary Breast Cancer Patients
Dr. Kazumi Horiguchi, Department of Surgery, Breast Oncology Unit, Cancer and Infectious Diseases Center of Tokyo Metropolitan Komagome Hospital, Japan

16:25-16:45

Title: Early Breast Cancer Diagnosis Using Dedicated rf Coils for High and Low Field MRI
Dr. Barbara Blasiak, Institute of Nuclear Physics, Polish Academy of Sciences, Poland

16:45-17:05

Panel Discussion

Title: Simulation of Breast Cancer Screening and Radiation Risk for Women with a Hereditary Increased Breast Cancer Risk
Dr. Marcel JW Greuter, Associate Professor, Department of Radiology, University Medical Center Groningen, University of Groningen, The Netherlands

Title: The Role of Breast Ultrasound Elastography in Clinical Practice
Dr. Su-Ming Tan, Chief, Department Surgery, Director, Breast Centre, Changi General Hospital, Singapore

Title: Mammographic Density and Association with Breast Cancer Risk: Epidemiologic and Tissue Correlates
Dr. Karthik Ghosh, Consultant, Breast Diagnostic Clinic, Mayo Clinic, USA

Title: Mammography Screening in Denmark. Past and Present
Dr. Ilse Vejborg, Chief Physician, Head of the Mammography Screening Programme in Capital Region of Denmark, Chairman of The Danish Breast Imaging Society, Section of Breast Imaging, University Hospital Rigshospitalet, Denmark

Title: Breast Carcinomas: Optimizing the Diagnosis by Ultrasound, Present and Future
Dr. Eduardo Fleury, Professor, Faculty of Medicine, Department of Radiology, Santa Casa de Misericórdia School of Medicine, Brazil

Title: Vasculization of Three-dimensional Power Doppler Ultrasound Correlated with Her-2 and ER Expression of Breast Cancer
Dr. Dar-Ren Chen,Professor, Comprehensive Breast Cancer Center, Changhua Christian Hospital, Taiwan

Title: A New Computer-aided Approach for Breast Cancer Diagnosis
Dr. Filipe Soares, Researcher, Siemens Healthcare Research Center, Portugal

Title: A Comparative Study of Mammography and Sonography along  with Histopathological Correlation in Evaluation of Palpable Breast Lesions at a General Hospital in Delhi, India 
Dr. Anuradha Sural, Consultant, Department of Radiodiagnosis, St.Stephen’s Hospital, India

Speech Opportunity Available

Panel Discussion

Dr. Dikoma C. Shungu, Professor of Physics in Radiology Psychiatry, and Physiology and Biophysics, Chief, Laboratory for Advanced MRS Research Citigroup Biomedical Imaging Center, Weill Medical College of Cornell University, USA

08:30-08:50

Title: High Field MRI (T4) for the Diagnosis and Treatment of Breast Cancer
Dr. Michael T. Nelson, Professor of Radiology, Department of Radiology, University of Minnesota Medical School, USA

Title: Advances in 1H MR Spectroscopic Imaging Technology for Measurement of Choline as a Reliable Aid for Early Diagnosis of Breast Cancer
Dr. Dikoma C. Shungu, Professor of Physics in Radiology Psychiatry, Weill Medical College of Cornell University, USA

09:10-09:30

Title: Clinical Experience of Using BSGI, a Meta-analysis
Dr. Douglas A. Kieper, Associate Research Professor,  Center for Advanced Medical Instrumentation, Hampton University; Vice President Of Science and Technology, Dilon Diagnostics, USA    

Title: Hemodynamic Dodelling and Quantitative Pharmacokinetic Analysis for Breast Cancer
Dr. Shanglian Bao, Professor In Medical Physics, Peking University, China

Title: Multiparametric Magnetic Resonance Imaging in Breast Cancer at 3 Tesla for Differentiation of Benign and Malign Lesions and as an Early Indicator of Therapy Response
Dr. Stephan Gruber, Assistant Professor, MR-Centre of Excellence, Medical University of Vienn, Austria

Coffee Break

Title: Molecular Breast Imaging - The Mayo Clinic Experience
Dr. Dietlind L. Wahner-Roedler, Professor of Medicine, Consultant, Breast Diagnostic Clinic, Division of General Internal Medicine, Mayo Clinic, USA

Title: Dynamic Angiothermography a New Functional Thecnique in Breast Imaging
Dr. Daniele Montruccoli, Gynaecologist-Oncologyst, Professor in Oncology at University La Sapienza in Rome; Head Breast Cancer Department, Geneva Foundation for Medical Education and Research, Italy 

Title: Shutter-Speed Model DCE-MRI for Discrimination of Benign and Malignant Breast Lesions
Dr. Wei Huang, Associate Scientist/Professor, Advanced Imaging Research Center, Oregon Health & Science University, USA

Title: Early Diagnosis of Breast Cancer by MRI using Dynamic and Functional MRI (1H MR Spectroscopy and Diffusion Weighted Imaging)
Dr. Hanaa Al-Khawari, Associate  Professor, Department of Clinical Radiology, Faculty of Medicine, Kuwait University, Kuwait

Panel Discussion

13:30-13:50

Title: The Surgical Management of the Axilla in Breast Cancer Patients with Clinically Node Negative Disease
Dr. Luis M. Samayoa, Associate Professor, Department of Pathology, Comprehensive Breast Cancer Center, University of Kentucky, USA

13:50-14:10

Title: Successful Outpatient Identification of the Sentinel Lymph Node with Ultrasound Using Microbubbles in Breast Cancer Patients
Dr. Peter Jones, Consultant Surgeon, Peggy Wood Breast Care Centre, Maidstone and Tunbridge Wells NHS Trust Hospital, UK

14:10-14:30

Title: Non-invasive and Reliable Method for Staging Axillary Lymph Nodes
Dr. Lina Arbash Meinel, Senior Research Scientist, Philips Research of North America; Visiting Scientist, University of Chicago, USA

14:30-14:50

Title: A Computer Aided Surgery for Sentinel Lymph Node Identification using Fluorescence Imaging and Image Overlay Navigation in Patients with Breast Cancer
Dr. Nobumi Tagaya, Associate Professor, Second Department of Surgery, Dokkyo Medical University, Japan

14:50-15:10

Title: Impact of Sentinel Node Results on Breast Cancer Management–Outcomes of Intra-operative and Multidisciplinary Management Decisions
Dr. J. David Beatty, Medical Director, Breast Surgical Clinic, Swedish Cancer Institute, USA

15:25-15: 45

Title: In Breast Cancer Patients Microbubble Enhanced Ultrasound Identification of the Sentinel Lymph Node (SLN) Allows Targeted Fine Needle Aspiration Cytology (FNAC) and Reduces Futile SLN Surgery
Dr. Sue Jones, Consultant Breast & Oncoplastic Surgeon, Peggy Wood Breast Care Centre, Maidstone Hospital, UK

13:30-13:55

Title: Breast Cancer Probed by Fluorescence and Raman Spectroscopy
Dr. Cheng-hui Liu, Senior Research Associate, IUSL, Department of Physics, City College of CUNY, USA

13:55-14:20

Title: Biopsy Techniques for non Palpable Lesions. Present and Future
Dr. Dionysios Koufoudakis, Consultant Breast Surgeon, IASO General Hospital, Greece

14:20-14:45

Title: Intraductal Approach to the Diagnosis of Intraductal Lesions
Dr. Tadaharu Matsunaga, Director, Akasaka Breast International Clinic; Associate Professor, Department of Breast, Tokyo Medical University Hachioji Medical Center, Japan

14:45-15:10

Title: Fine Needle Aspiration Biopsy of the Breast
Dr. Teresa M. Alasio, Assistant Professor, Department of Pathology at SUNY Downstate Medical Center in Brooklyn, USA

15:10-15:25

Coffee Break

15:25-15:50

Title: Us-guided Needle Core Biopsy (14 G) of Suspicious Axillary Lymph Nodes: Our Experience with 216 Cases
Dr. Luis Javier Pina Insausti, Head of Breast Imaging Section in The Hospital Virgen del Camino, Department of Radiology, University Clinic, University of Navarra, Spain

15:50-16:15

Title: The Role of Sentinel Lymph Node Biopsy in Ductal Carcinoma in Situ
Dr. Hasan Karanlik,Assistant Professor, Department of Surgical Oncology, Institute of Oncology, Istanbul University, Turkey

16 :15-16 :40

Title: Roll and Snoll Technique: The Experience of the European Institute of Oncology on 2917 Patients from 2000 to 2006
Dr. Simonetta Monti, Senology Division and Nuclear Medicine Division of European Institute of Oncology of Milan, Italy

16:40-17:05

Panel Discussion

Title: Circulating Tumor Cells - Clinical Relevance and Applications
Dr. Beverly C. Handy, Assistant Professor, Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, USA

Title: Role of Positron-Emission-Tomography (PET) in the Management of Breast Cancer. Present and Future Directions
Dr. Rashid Fawwaz, Professor, College of Physicians and Surgeons, Columbia University, USA

Title: The Clinical Role of FDG-PET Imaging in the Management of the Patients with Breast Cancer
Dr. Muammer Urhan, Department of Nuclear Medicine, GATA Haydarapasa Istanbul, Turkey    

Dr. Tsu-Yin Wu, Director, Associate Professor, Healthy Asian Americans Project School of Nursing, University of Michigan; Eastern Michigan University, USA

Title: Prevention and Early Detection on Breast Cancer: A Cross Cultural Perspective
Dr. Tsu-Yin Wu, Director, Associate Professor, Healthy Asian Americans Project School of Nursing, University of Michigan; Eastern Michigan University, USA

Title: Physical Examination is a Valuable Tool in the Follow up of Young Women with a History of Early Breast Cancer
Dr. Geertruida H De Bock, Associate Professor, Department of Epidemiology, University Medical Center Groningen, University of Groningen, The Nederlands

Title: Iranian Immigrant Women’s Knowledge of Breast Cancer and Screening
Dr. Mandana Vahabi, Associate Professor, Daphne Cockwell School of Nursing, Ryerson University, Canada

Title: Breast Cancer and Population-based Mammography Screening in Finland
Dr. Pirjo Immonen-Raiha, Chief Doctor of Healthcare Assessment, Assistant Professor of General Pracrtice, Hospital District of Southwest Finland, University Hospital of Turku, Finland

Title: Protein Profile Analysis of the Breast Nipple Aspirate Fluid from Healthy Japanese Women
Dr. Tomoyuki Aruga, Senior Medical Staff, Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, NPO Biomarker and Cancer Prevention Frontier, Japan

Title: Communicating Breast Cancer and Cancer Screening Risks to Migrants and Minority Ethnic Women: The Evaluation of an Interactive Risk-communication (IRC) Tool Using a Cross-over Trial
Dr. Lai Fong Chiu, Senior Research Fellow, Leeds Institutes of Health Sciences, University of Leeds, UK

Title: The Prevalence of Breast Cancer Risk Factors in UAE Screened Population
Dr. Hajer Al Hosani, Director of Central Department, Maternal and Child Health, United Arab Emirates

Title: Integrated Breast Cancer Control Program a Pilot Model in Sao Paulo Brazil
Dr. Marianne Pinotti, Professor, Director of the Department of Mastology, Prof. Pinotti's Clinic, Brazil

Title: A Pilot Study on Effectiveness of Short Text Messages (SMS) as a Reminder System for Making Working Women from Delhi Breast Aware
Dr. Anita khokhar, Associate Professor, Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjang Hospital, India

Title: The Utilization and Efficacy of Long-term Follow up of Chinese Breast Cancer Patients
Dr. Wenli Lu, Lecturer, Department of Health Statistics, Faculty of Public Health, Tianjin Medical University, China

13:30-13:55

Title: Improved Disease Control with Lutenizing Hormone-Releasing Hormone (LH-RH) in High Risk Premenopausal Breast Cancer Patients (HR-Pre-BC)
Dr. Francesco Recchia, Professor and Director, Clinical Oncology, Civilian Hospital, University of L’aquila, Italy

13:55-14:20

Title: Biomarkers for Prediction of Treatment Efficacy in Breast Cancer Patients
Dr. Nils Brunner,Professor, Section for Pathobiology, Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen, Denmark

14:20-14:45

Title: Update on the Role of Adjuvant Targeted Therapy in the Management of Breast Cancer
Dr. Alaa Kandil, Professor of Clinical Oncology, Alexandria School of Medicine, Egypt

14:45-15:10

Title: Anthracycline and Concurrent Radiotherapy Significantly Reduced Loco-regional Breast Cancer Relapse Rate
Dr. Nabil Ismaili, Medical Doctor, National Institute of Oncology, Morocco

Title: Image-based Treatment Planning of the Post-lumpectomy Breast Utilizing CT and 3T MRI
Dr. Geraldine Jacobson, Clinical Professor, Department of Radiation Oncology, University of Iowa Hospitals and Clinics, USA

Title: Preliminary Experience with Single Fraction Intra-operative Radiotherapy Following Lumpectomy
Dr. Frederick M. Dirbas, Associate Professor of Surgery, Stanford University School of Medicine, USA

Title: Intraoperative Radiotherapy of Breast Cancer with Low Energy X-rays
Dr. Marc Sütterlin, Professor, Heidelberg University; Chairman and Head, Department of Obstetrics and Gynaecology, University Medical Center Mannheim, Germany

16:25-16:45

Title: Intraoperative Radiotherapy in Breast Cancer
Dr. Peter Van Dam, Professor, Departments of Gynecology, Oncologic Centre, Sint Augustinus Hospital, Belgium

Panel Discussion

Title: Nab-paclitaxel Efficacy and Safety in the Treatment of Metastatic Breast Cancer. Overview of Clinical Data.
Dr. Neville Davidson, Professor, a Fellow of the Royal College of Physicians and the Royal College of Radiologists, UK

Dr. Yelena Novik, Medical Director, Clinical Trials Office, New York University Cancer Institute, New York University School of Medicine, USA

15:45-16:05

Title: Targeted Therapies in Breast Cancer: Experience from Recent Clinical Trials and Impact on Clinical Trials Design
Dr. Yelena Novik, Medical Director, Clinical Trials Office, New York University Cancer Institute, New York University School of Medicine, USA

16:05-16:25

Title: Bevacizumab Plus Docetaxel and Cisplatin for Metastatic Breast Cancer: Taipei Medical University Hospital Experiences on Chinese/Taiwanese and Consideration Based on Pharmacoeconomics
Dr. Cheng-Jeng Tai, Director, Section of Hematology-Oncology, Department of Medicine, Taipei Medical University Hospital, Taiwan

16:25-16:45

Title: Comparison of HER-2 Overexpression in Primary Breast Cancer and Metastatic Sites and its Effect on Biological Targeting Therapy Decision
Dr. Jamal Zidan, Professor, Department of Oncology, Ziv Medical Center; Faculty of Medicine, Technion, Haifa, Israel 

16:45-17:05

Title: Sonodynamic and Photodynamic Therapy in Advanced Refractory Breast Carcinoma---A Developing New form of Systemic Tumor Target Therapy
Dr. Xiaohuai Wang, Director and Chief, Department of Oncology, General Hospital of PLA Guangzhou Command, China

Title: Antibodies against HERV-K: Novel Therapeutic Agents for Breast Cancers Expressing HERV-K env Protein
Dr. Feng Wang-Johanning, Associate Professor, Department of Veterinary Sciences, Department of Immunology, The University of Texas M. D. Anderson Cancer Center, USA

Title: Antibodies against Human Endogenous Retroviruses as Biomarkers of Early Breast Cancer
Dr. Gary Johanning, Associate Professor, Department of Veterinary Sciences, The University of Texas M. D. Anderson Cancer Center, USA

Title: Cosmetic Outcome and Percentage of Breast Volume Excision in Oncoplastic Breast Conserving Surgery
Dr. Chan Sharon Wing Wai, Associate Consultant, Clinical Director, KEC Breast Centre, Department of Surgery, United Christian Hospital, Hong Kong, China

Title:  Refraining from Axillary Surgery, Long Term Results from IBCSG Trial and SweBCG Kohort Study
Dr. Stig Holmberg, Assistant Professor of Surgery, Sahlgrenska University Hospital, Sweden

Coffee Break

Title: Radiofrequency Ablation for Breast Cancer: A Comparative Study of Two Needle Designs
Dr. Wai-ka Hung, Senior Medical Officer, Department of Surgery, The Breast Centre, Kwong Wah Hospital, Hong Kong, China

10:50-11:15

Title: MR Guided Focused Ultrasound Surgery for Early Breast Cancer
Dr. Hidemi Furusawa, Medical Doctor, Department of Breast Surgical Oncology, Breastopia Namba Hospital, Japan 

11:15-11:40

Title: Oncoplastic Breast Surgery for Early and Advanced Breast Cancer
Dr. Hoyong Park, Associate Professor, Department of Surgery, College of Medicine, Kyungpook National University, Korea

Title: Vector Prime-protein Boost Vaccine for Breast Cancer
Dr. Albert B. Deisseroth, Medical Officer, Food and Drug Administration, USA

Title: Management of DCIS
Dr. Nam-Sun Paik, Professor, Chief, Division of Breast. Konkuk University Medical Center, Korea